Searched for
INSULIN SENSITISER
- Unfinished Agenda: Kallam Anji Reddy sets lofty targets for philanthropyDr Reddy has set lofty targets for his philanthropy - like generating a million livelihoods by 2010 or providing safe drinking water to all...
- Piramal Life may unveil new chemical entity by 2011Piramal Life Sciences, the listed research and development (R&D) subsidiary of Piramal Healthcare, is hoping to hit the market with its fir...
- People turning to medicines to check the onset of diabetesUnable to squeeze in enough physical activity in their everyday life due to erratic work schedules, the young in India are increasingly tur...
- DRL’s anti-diabetes drug to hit market by ’11Dr Reddy’s anti-diabetes molecule Balaglitazone, which has entered the final phase of clinical development, is expected to hit the world ma...
- How Dr Reddy's chased diabetes molecule dreamDr Reddy’s pursuit of past 13 years for the type 2 diabetes molecule is in its last lap, with the product entering the final phase of clini...
- Foreign players look at India to develop lower-cost drugsGerman pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
- Wanted, MNC alliesNew drug discoveries are the pharmaceutical equivalent of an alchemist’s search for a magic formula to turn base metals into gold.
Load More- DRL’s anti-diabetes drug to hit market by ’11